Literature DB >> 11898923

Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature.

R Palacios1, J Santos, P Valdivielso, M Márquez.   

Abstract

Systemic lupus erythematosus (SLE) and infection with the human immunodeficiency virus (HIV) are rarely seen in the same patient. Both diseases share clinical and serological features and the differential diagnosis is difficult, with renal manifestations being of special interest. To date, 29 cases of association between the two diseases have been reported, but the diagnosis was simultaneous in just two of these and only 18 fulfilled the ARA criteria for the diagnosis of SLE. Most patients experienced an improvement in their SLE after development of their HIV associated immunosuppression and a reactivation of lupus manifestations has also been noted after immunological recovery secondary to antiretroviral therapy. We present the case of a woman in whom HIV and SLE with renal involvement were diagnosed simultaneously.

Entities:  

Mesh:

Year:  2002        PMID: 11898923     DOI: 10.1191/0961203302lu141cr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  22 in total

Review 1.  Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Authors:  Barton F Haynes; M Anthony Moody; Laurent Verkoczy; Garnett Kelsoe; S Munir Alam
Journal:  Hum Antibodies       Date:  2005

2.  An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

Authors:  Mattia Bonsignori; Kevin Wiehe; Sebastian K Grimm; Rebecca Lynch; Guang Yang; Daniel M Kozink; Florence Perrin; Abby J Cooper; Kwan-Ki Hwang; Xi Chen; Mengfei Liu; Krisha McKee; Robert J Parks; Joshua Eudailey; Minyue Wang; Megan Clowse; Lisa G Criscione-Schreiber; M Anthony Moody; Margaret E Ackerman; Scott D Boyd; Feng Gao; Garnett Kelsoe; Laurent Verkoczy; Georgia D Tomaras; Hua-Xin Liao; Thomas B Kepler; David C Montefiori; John R Mascola; Barton F Haynes
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

3.  Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide.

Authors:  Indrajit Hazarika; Bhabani Prasad Chakravarty; Sangit Dutta; Neelakshi Mahanta
Journal:  Clin Rheumatol       Date:  2005-08-16       Impact factor: 2.980

Review 4.  Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Frederick W Alt; Ming Tian
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 5.  Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.

Authors:  Laurent Verkoczy; Marilyn Diaz
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

Review 6.  Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.

Authors:  Laurent Verkoczy
Journal:  Adv Immunol       Date:  2017       Impact factor: 3.543

Review 7.  Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Garnett Kelsoe; M Anthony Moody; Barton F Haynes
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

Review 8.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

Review 9.  Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature.

Authors:  Manuela Carugati; Marco Franzetti; Alessandro Torre; Riccardo Giorgi; Augusto Genderini; Francesco Strambio de Castilla; Cristina Gervasoni; Agostino Riva
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

Review 10.  SLE and infections.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.